
The anthracyclines doxorubicin (A) and epirubicin (E) are among the most active agents for breast cancer.

Your AI-Trained Oncology Knowledge Connection!


The anthracyclines doxorubicin (A) and epirubicin (E) are among the most active agents for breast cancer.

February 18th 2011